BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19030713)

  • 1. Effect of melatonin administration on subjective sleep quality in chronic obstructive pulmonary disease.
    Nunes DM; Mota RM; Machado MO; Pereira ED; Bruin VM; Bruin PF
    Braz J Med Biol Res; 2008 Oct; 41(10):926-31. PubMed ID: 19030713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study.
    Medeiros CA; Carvalhedo de Bruin PF; Lopes LA; Magalhães MC; de Lourdes Seabra M; de Bruin VM
    J Neurol; 2007 Apr; 254(4):459-64. PubMed ID: 17404779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Melatonin Administration on Sleep Quality in Sulfur Mustard Exposed Patients with Sleep Disorders.
    Mousavi SS; Shohrati M; Vahedi E; Abdollahpour-Alitappeh M; Panahi Y
    Iran J Pharm Res; 2018; 17(Suppl):136-144. PubMed ID: 29796038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of MElatonin in children with neurodevelopmental disorders and impaired sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS).
    Appleton RE; Jones AP; Gamble C; Williamson PR; Wiggs L; Montgomery P; Sutcliffe A; Barker C; Gringras P
    Health Technol Assess; 2012; 16(40):i-239. PubMed ID: 23098680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of exogenous melatonin administration in improvement of sleep quality in patients with chronic obstructive pulmonary disease.
    Halvani A; Mohsenpour F; Nasiriani K
    Tanaffos; 2013; 12(2):9-15. PubMed ID: 25191456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM-CP): a study protocol.
    Adam R; Kanakarajan S; Onyeakazi U; Columb M; Galley H
    BMJ Open; 2020 Mar; 10(3):e034443. PubMed ID: 32184313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged-release melatonin in Parkinson's disease patients with a poor sleep quality: A randomized trial.
    Ahn JH; Kim M; Park S; Jang W; Park J; Oh E; Cho JW; Kim JS; Youn J
    Parkinsonism Relat Disord; 2020 Jun; 75():50-54. PubMed ID: 32480307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
    Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW;
    PLoS Med; 2018 Jun; 15(6):e1002587. PubMed ID: 29912983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial.
    Bourne RS; Mills GH; Minelli C
    Crit Care; 2008; 12(2):R52. PubMed ID: 18423009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Melatonin on Sleep and Pain After Total Knee Arthroplasty Under Regional Anesthesia With Sedation: A Double-Blind, Randomized, Placebo-Controlled Pilot Study.
    Kirksey MA; Yoo D; Danninger T; Stundner O; Ma Y; Memtsoudis SG
    J Arthroplasty; 2015 Dec; 30(12):2370-5. PubMed ID: 26173613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial.
    Büchele F; Hackius M; Schreglmann SR; Omlor W; Werth E; Maric A; Imbach LL; Hägele-Link S; Waldvogel D; Baumann CR
    JAMA Neurol; 2018 Jan; 75(1):114-118. PubMed ID: 29114733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
    McCleery J; Cohen DA; Sharpley AL
    Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of melatonin for sleep disturbance following traumatic brain injury: a randomised controlled trial.
    Grima NA; Rajaratnam SMW; Mansfield D; Sletten TL; Spitz G; Ponsford JL
    BMC Med; 2018 Jan; 16(1):8. PubMed ID: 29347988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin improves sleep in asthma: a randomized, double-blind, placebo-controlled study.
    Campos FL; da Silva-Júnior FP; de Bruin VM; de Bruin PF
    Am J Respir Crit Care Med; 2004 Nov; 170(9):947-51. PubMed ID: 15306531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sleep disorders in Parkinson's disease without dementia: a comparative randomized controlled study of melatonin and clonazepam].
    Litvinenko IV; Krasakov IV; Tikhomirova OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12):26-30. PubMed ID: 23388588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebo-controlled study.
    Garzón C; Guerrero JM; Aramburu O; Guzmán T
    Aging Clin Exp Res; 2009 Feb; 21(1):38-42. PubMed ID: 19225268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparative Study on the Use of Alprazolam and Melatonin for Sleep Disturbances in Hemodialysis Patients.
    Asghar MS; Ahsan MN; Jawed R; Rasheed U; Ali Naqvi SA; Hassan M; Yaseen R; Mallick N; Zehra M; Saleem M
    Cureus; 2020 Nov; 12(11):e11754. PubMed ID: 33403184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial.
    Xu H; Zhang C; Qian Y; Zou J; Li X; Liu Y; Zhu H; Meng L; Liu S; Zhang W; Yi H; Guan J; Chen Z; Yin S
    Sleep Med; 2020 Dec; 76():113-119. PubMed ID: 33157425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.
    Singer C; Tractenberg RE; Kaye J; Schafer K; Gamst A; Grundman M; Thomas R; Thal LJ;
    Sleep; 2003 Nov; 26(7):893-901. PubMed ID: 14655926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of Exogenous Melatonin as a Treatment Modality for Sleep and Psychiatric Disorders in Hemodialysis Patients.
    Yousef EA; El Wasify MA; Baddor AA; Sobh MA
    Saudi J Kidney Dis Transpl; 2022; 33(1):1-15. PubMed ID: 36647974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.